Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center

Journal of Clinical Microbiology

Volumn 47, Issue 3, 2009, Pages 590-595

  Ganga, Roopa ^a   Riederer, Kathleen ^a   Sharma, Mamta ^a   Fakih, Mohamad G ^a   Johnson, Leonard B ^a   Shemes, Stephen ^a   Khatib, Riad ^a  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFAZOLIN; NAFCILLIN; PENICILLIN BINDING PROTEIN 2A; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENE CASSETTE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCAL BACTEREMIA;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; DNA, BACTERIAL; FEMALE; GENOTYPE; HUMANS; INPATIENTS; LENGTH OF STAY; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE; YOUNG ADULT;

IVA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 62749124885     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00397-08     Document Type: Article

References (39)

1. Arrecubieta, C., T. Asai, M. Bayern, A. Loughma, J. R. Fitzgerald, C. E. Shelton, H. M. Baron, N. C. Deng, Y. Naka, T. J. Foster, and F. D. Lowy. 2006. The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections. J. Infect. Dis. 193:1109-1119.
2. Benton, B. M., J. P. Zhang, S. Bond, C. Pope, T. Christian, L. Lee, K. M. Winterberg, M. B. Schmid, and J. M. Buysse. 2004. Large-scale identification of genes required for full virulence of Staphylococcus aureus. J. Bacteriol. 186:8487-8489.
3. Bhattacharya, D., H. Carleton, C. J. Tsai, E. J. Baron, and F. Perdreau-Remington. 2007. Differences in clinical and molecular characteristics of skin and soft tissue methicillin-resistant Staphylococcus aureus isolates between two hospitals in northern California. J. Clin. Microbiol. 45:1798-1803.
4. Boyle-Varvra, S., and R. S. Daum. 2007. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab. Investig. 87:3-9.
5. Charlson, M. E., P. Pompei, K. L. Ales, and C. R. MacKenzie. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383.
6. Davis, S. L., M. J. Rybak, M. Amjad, G. W. Kaatz, and P. S. McKinnon. 2006. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 27:1025-1031.
7. Deyo, R. A., D. C. Cherkin, and M. A. Ciol. 1992. Adapting a clinical comorbidity index for use with ICD-9 CM administrative database. J. Clin. Epidemiol. 45:613-619.
8. Diep, B. A., H. A. Carleton, R. F. Chang, G. F. Sensabaugh, and F. Perdreau-Remington. 2006. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 193:1495-1503.
9. Fowler, V. G., Jr., C. L. Nelson, L. M. McIntyre, B. N. Kreiswirth, A. Monk, G. L. Archer, J. Federspiel, S. Naidich, B. Remortel, T. Rude, P. Brown, L. B. Reller, G. R. Corey, and S. R. Gill. 2007. Potential association between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J. Infect. Dis. 196:738-747.
10. Fowler, V. G., Jr., G. Sakoulas, L. M. McIntyre, V. G. Meka, R. D. Arbeit, C. H. Cabell, M. E. Stryjewski, G. M. Elipoulos, L. B. Reller, G. R. Corey, T. Jones, N. Lucindo, M. R. Yeaman, and A. S. Bayer. 2004. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J. Infect. Dis. 190:1140-1149.
11. Gill, S. R., D. E. Fouts, G. L. Archer, E. F. Mongodin, R. T. Deboy, J. Ravel, I. T. Paulsen, J. F. Kolonay, L. Brinkac, M. Beanan, R. J. Dodson, S. C. Daugherty, R. Madupu, S. V. Angiuoli, A. S. Durkin, D. H. Haft, J. Vamathevan, H. Khouri, T. Utterback, C. Lee, G. Dimitrov, L. Jiang, H. Qin, J. Weidman, K. Tran, K. Kang, I. R. Hance, K. E. Nelson, and C. M. Fraser. 2005. Insights on the evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187:2426-2438.
12. Haslinger-Loffler, B., B. C. Kahl, M. Grundmeier, K. Strangfeld, B. Wagner, U. Fischer, A. L. Cheung, G., Peters, K. Schultze-Osthoff, and B. Sinha. 2005. Multiple virulence factors are required for Staphylococcus aureus induced apoptosis in endothelial cells. Cell. Microbiol. 7:1087-1097.
13. Hussain, F. M., S. Boyle-Vavra, P. B. Shete, and R. S. Daum. 2002. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. J. Infect. Dis. 186:661-667.
14. Jacobsson, G., S. Dashti, T. Wahlberg, and R. Andersson. 2007. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand. J. Infect. Dis. 39:6-13.
15. Jarraud, S., C. Mougel, J. Thioulouse, G. Lina, H. Meugnier, F. Forey, X. Nesme, J. Etienne, and F. Vandenesch. 2002. Relationship between Staphylococcus aureus genetic background, virulence factors agr groups (alleles) and human disease. Infect. Immun. 70:631-641.
16. Khatib, R., K. Riederer, S. Saeed, L. B. Johnson, M. G. Fakih, M. Sharma, M. S. Tabriz, and A. Khosraovaneh. 2005. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection. Clin. Infect. Dis. 41:594-598.
17. Khatib, R., L. B. Johnson, M. G. Fakih, K. Riederer, A. Khosrovaneh, S. Tabriz, M. Sharma, and S. Saeed. 2006. Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients, and outcome. Scand. J. Infect. Dis. 38:7-14.
18. Kim, S. H., W. B. Park, K. D. Lee, C. L. Kang, H. B. Kim, M. D. Oh, E. C. Kim, and K. W. Choe. 1003. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin. Infect. Dis. 37:794-799.
19. King, M. D., B. J. Humphrey, Y. F. Wang, E. V. Kourbatova, S. M. Ray, and H. M. Blumberg. 2006. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med. 144:309-317.
20. Klevens, R. M., M. A. Morrison, J. Nadle, S. Petit, K. Gersham, S. Ray, L. H. Harrison, R. Lynfield, G. Dumyati, J. M. Townes, A. S. Craig, E. R. Zell, G. E. Fosheim, L. K. McDougal, R. B. Carey, and S. K. Fridkin. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771.
21. Kumar, A., P. Ray, M. Kanwar, M. Sharma, and S. Varma. 2006. Analysis of genetic diversity among Staphylococcus aureus isolates from patients with deep-seated and superficial staphylococcal infections using pulse-field gel electrophoresis. Scand. J. Infect. Dis. 38:418-426.
22. Le Gall, J. R., S. Lemeshow, and F. Saulnier. 1993. A new simplified acute physiology score (SAPS II) based on a European/North American muticenter study. JAMA 270:2957-2963.
23. Li, J. S., D. J. Sexton, N. Mick, R. Nettle, V. G. Fowler, Jr., T. Ryan, T. Bashore, and G. R. Corey. 2000. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin. Infect. Dis. 30:633-638.
24. Lindsay, J. A., C. E. Moore, N. P. Day, S. J. Peacock, A. A. Witney, R. A. Stabler, S. E. Husain, P. D. Butcher, and J. Hinds. 2006. Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J. Bacteriol. 188:669-676.
25. Lomholt, H., K. E. Andersen, and M. Kilian. 2005. Staphylococcus aureus clonal dynamics and virulence factors in children with atopic dermatitis. J. Investig. Dermatol. 125:977-982.
26. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520-532.
27. Moran, G. J., A. Krishnadasan, R. J. Gorwitz, G. E. Fosheim, L. K. McDougal, R. B. Carey, D. A. Talan, et al. 2006. Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
28. Morreillon, P., Y.-A. Que, and M. P. Glauser. 2005. Staphylococcus aureus (including staphylococcal toxic shock), p. 2321-2351. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 6th ed., vol. 2. Elsevier, Philadelphia, PA.
29. Peacock, S. J., C. E. Moore, A. Justice, M. Kantaznou, L. Story, K. Mackie, G. O'Neill, and N. P. J. Day. 2002. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect. Immun. 70:4987-4996.
30. Rooijakkers, S. H., K. P. van Kessel, and J. A. van Strijp. 2005. Staphylococcal innate immune evasion. Trends Microbiol. 13:596-601.
31. Sakoulas, G., G. M. Eliopoulos, R. C. Moellering, Jr., R. P. Novick, L. Venkataraman, C. Wennersten, P. C. DeGirolami, M. J. Schwaber, and H. S. Gold. 2003. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J. Infect. Dis. 187:929-938.
32. Soriano, A., J. A. Martinez, J. Mensa, F. Marco, M. Almela, A. Moreno-Martinez, F. Sanchez, I. Muoz, M. T. Jimenez de Anta, and E. Soriano. 2000. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin. Infect. Dis. 30:368-373.
33. Trindade, P. A., R. L. Pacheco, S. F. Costa, F. Rossi, A. A. Barone, E. M. Mamizuka, and A. S. Levin. 2005. Prevalence of SCCmec type IV in nosocomial bloodstream isolates of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43:3435-3437.
34. Tsigrelis, C., M. D. Armstrong, N. E. Vlahakis, J. A. Batsis, and L. M. Baddour. 2007. Infective endocarditis due to community-associated methicillin-resistant Staphylococcus aureus in injection drug users may be associated with Panton-Valentine leukocidin-negative strains. Scand. J. Infect. Dis. 39:299-302.
35. Tsuji, B. T., M. J. Rybak, C. M. Cheung, M. Amjad, and G. W. Kaatz. 2007. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. Diagn. Microbiol. Infect. Dis. 58:41-47.
36. Watts, A., D. Ke, Q. Wang, A. Pillay, A. Nicholson-Weller, and J. C. Lee. 2005. Staphylococcus aureus strain that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence. Infect. Immun. 73:3502-3511.
37. Wertheim, H. F. L., W. B. van Leeuwen, S. Snijders, M. C. Voss, C. M. Vandenbroucke-Grauls, J. A. Kluymans, H. A. Verbugh, and A. Belkum. 2005. Association between Staphylococcus aureus genotype, infection, and in-hospital mortality: a nested case-control study. J. Infect. Dis. 192:1196-1200.
38. Wylie, J. L., and D. L. Nowicki. 2005. Molecular epidemiology of community- and health care-associated methicillin-resistant Staphylococcus aureus in Manitoba, Canada. J. Clin. Microbiol. 43:2830-2836.
39. Zhang, K., J. A. McClure, S. Elsayed, T. Louie, and J. M. Conly. 2005. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43:5026-5033.